Ms contin and Hyperreflexia - a phase IV clinical study of FDA data

Summary:

Hyperreflexia is reported as a side effect among people who take Ms contin (morphine sulfate), especially for people who are female, 60+ old, also take Premarin, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Hyperreflexia when taking Ms contin. It is created by eHealthMe based on reports of 68,873 people who have side effects when taking Ms contin from the FDA, and is updated regularly.

What is Ms contin?

Ms contin has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 69,288 Ms contin users. Check the latest studies of Ms contin.

What is Hyperreflexia?

Hyperreflexia (overactive or over responsive reflexes) is found to be associated with 468 drugs and 645 conditions by eHealthMe. Check the latest studies of Hyperreflexia.

On Feb, 11, 2026

68,873 people reported to have side effects when taking Ms contin.
Among them, 6 people (0.01%) have Hyperreflexia.

Among these 6 people:

What is the gender of people who have Hyperreflexia when taking Ms contin? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Hyperreflexia when taking Ms contin? *

What are other drugs people take besides Ms contin? *

What are other side effects people have besides Hyperreflexia? *

Head Injury: 4 people, 66.67%
Weakness: 4 people, 66.67%
Bleeding Into The Skin: 3 people, 50.00%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 3 people, 50.00%
Fall: 3 people, 50.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 50.00%
Dyspnea Exertional: 3 people, 50.00%
Heart Rate Increased: 3 people, 50.00%
High Blood Pressure: 2 people, 33.33%
Myopathy (a muscular disease in which the muscle fibres do not function): 2 people, 33.33%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 3 people, 50.00%
Stress And Anxiety: 2 people, 33.33%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 33.33%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 16.67%
Pneumonia: 1 person, 16.67%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 16.67%
Nervousness: 1 person, 16.67%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 16.67%
Lung Disorder (lung disease): 1 person, 16.67%
Intervertebral Disc Protrusion (spinal disc protrusion): 1 person, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Ms contin and have Hyperreflexia?

- Check whether Hyperreflexia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ms contin:

Ms contin (69,288 reports)

Hyperreflexia treatments and more:

Hyperreflexia (4,677 reports)

Browse all side effects of Ms contin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperreflexia:

Hyperreflexia (468 drugs)

Browse all the conditions that are associated with Hyperreflexia:

Hyperreflexia (645 conditions)

Related publications that referenced our studies

Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate (the active ingredients of Ms contin) and Ms contin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.